Maxcyte (MXCT) Inventory (2020 - 2026)

Maxcyte (MXCT) has reported Inventory for 7 consecutive years, with $7.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory fell 1.7% year-over-year to $7.8 million in Q2 2026; TTM through Jun 2026 was $7.8 million, a 1.7% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, down 15.34% from the prior year.
• Inventory was $7.8 million for Q2 2026 at Maxcyte, up from $7.6 million in the prior quarter.
• Over five years, Inventory peaked at $12.5 million in Q3 2023 and troughed at $6.6 million in Q1 2022.
• A 5-year average of $9.2 million and a median of $8.4 million in 2022 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 90.71% in 2022 and tumbled 30.82% in 2025, its largest moves.
• Over 5 years, Inventory stood at $8.6 million in 2022, then soared by 42.51% to $12.2 million in 2023, then decreased by 27.11% to $8.9 million in 2024, then dropped by 15.34% to $7.5 million in 2025, then increased by 3.33% to $7.8 million in 2026.
• The last three Inventory figures came in at $7.8 million (Q2 2026), $7.6 million (Q1 2026), and $7.5 million (Q4 2025), per Business Quant data.